Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

PreveCeutical, UniQuest link up for pain treatments
March 2018
SHARING OPTIONS:

VANCOUVER—PreveCeutical Medical Inc. has begun a research and option agreement with the University of Queensland (UQ) and UniQuest Pty Limited, the main commercialization company of UQ. In conjunction with the agreement, the organizations will conduct a research program to expand the application of their disulfide linker technology and pursue development of non-addictive analgesics for alleviating pain. The multi-phase program was slated to begin March 1, led by Dr. Harendra Parekh, UQ researcher and chief research officer of PreveCeutical, in collaboration with associate professor Peter Cabot, UQ School of Pharmacy’s pain and inflammation pharmacology expert. PreveCeutical will own all intellectual property developed under the auspices of this agreement, and will retain an option to negotiate an exclusive worldwide license to UniQuest’s background intellectual property, for which it will make milestone and royalty payments to UniQuest.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.